Form4insider filings, from the source

SEC Form 4 · accession 0001562180-17-002466

BIO-TECHNE Corp · TECH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kevin S Gould
Officer — SVP Clinical Controls
Period of report
Jul 9, 2017
Accepted (ET)
Jul 11, 2017 · 5:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jul 9, 2017F312$117.68D1,355D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF2,F3—holding—————Common Stock2,1112,111D
Stock Options (Right to Buy)F4$106.59holding————Aug 18, 2023Common Stock17,37117,371D
Stock Options (Right to Buy)F3$106.59holding————Aug 18, 2023Common Stock13,02813,028D
Stock Options (Right to Buy)F5$97.23holding————Jul 9, 2022Common Stock50,00050,000D
Stock Options (Right to Buy)F6$97.23holding————Jul 9, 2022Common Stock15,00015,000D
Stock Options (Right to Buy)F7$88.23holding————Jan 4, 2023Common Stock10,00010,000D

Explanation of responses